Home › Funds › DUMAC, INC. › SGMT

DUMAC, INC. position in SGMT

SAGIMET BIOSCIENCES INC COM SER A · Health Care

DUMAC, INC. reported holding 71,192 shares of SGMT (SAGIMET BIOSCIENCES INC COM SER A) in its Q2 2026 13F filing — a position valued at US$550K, representing 0.05% of its reported portfolio and ranking #14 among its reported holdings. DUMAC, INC. has disclosed SGMT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)71.19K sh
Reported value held$550.31K
Portfolio Weight0.05%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DUMAC, INC.'s SGMT position evolved

DUMAC, INC. first disclosed a stake in SGMT in Q3 2023 at 204,123 shares (US$1.8M). Across 10 filings, DUMAC, INC. increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 71,192 shares valued at US$550K. Notable position changes include a 49% trim in Q2 2025 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 204.12K $1.80M New
Q4 2023 204.12K $1.11M Hold
Q1 2024 189.39K $1.03M Reduce
Q3 2024 189.39K $524.62K Hold
Q4 2024 163.51K $735.81K Reduce
Q1 2025 147.35K $480.36K Reduce
Q2 2025 75.00K $571.50K Reduce
Q4 2025 71.19K $421.46K Reduce
Q1 2026 71.19K $371.98K Hold
Q2 2026 71.19K $550.31K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SGMT and 13F data

SGMT (SAGIMET BIOSCIENCES INC COM SER A) is a Health Care company. 59 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$22.6M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGMT

All SGMT fund holders →

FAQ

How long has DUMAC, INC. held SGMT?

DUMAC, INC. has disclosed SGMT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is DUMAC, INC.'s current position in SGMT?

As of Q2 2026, DUMAC, INC. holds 71.19K shares of SGMT (SAGIMET BIOSCIENCES INC COM SER A), valued at $550.31K, representing 0.05% of its reported portfolio and ranking #14.

Has DUMAC, INC. been buying or selling SGMT?

In the latest 13F filing (Q2 2026), DUMAC, INC. held unchanged its position in SGMT.

Which other funds hold SGMT?

Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.